Vedolizumab in paediatric IBD
Surgical closure, mainly with glue injection and anti-tumour necrosis factor α, in perianal CD
Etrolizumab for maintenance of remission in UC
Infliximab vs conventional therapy in pediatric CD
Lyophilised oral microbiota transplantation for UC
Tofacitinib in UC
Mirikizumab phase 2 in CD
Upadacitinib in UC induction and maintenance
Steroid exposure and perinatal outcomes
Vedolizumab SC in CD